PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

World-first trial shows benefits of finding, treating undiagnosed asthma and COPD

World-first trial shows benefits of finding, treating undiagnosed asthma and COPD
2024-05-19
(Press-News.org) Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) improved their health and reduced their healthcare visits for respiratory symptoms in the year after diagnosis, according to a world-first clinical trial published in the New England Journal of Medicine.

"It's estimated that 70 per cent of people with asthma or COPD go undiagnosed." said study lead Dr. Shawn Aaron, a senior scientist and lung specialist at The Ottawa Hospital and professor at the University of Ottawa. "This is the first study to prove that treating those people makes a real difference to their health and quality of life."

How did the research team find undiagnosed cases?

To find people with undiagnosed asthma and COPD, the research team called random phone numbers at 17 study sites across Canada from 2017 to 2023. An automated call asked whether any adults in the household had unexplained shortness of breath, wheezing, prolonged cough or were coughing up mucus in the past six months.

The 26,905 people who reported these symptoms completed questionnaires. Those most likely to have asthma or COPD did a spirometry breathing test, the gold standard for diagnosis.

A total of 595 people were diagnosed with either asthma or COPD, and 508 agreed to participate in a randomized controlled trial to compare different types of care.

Half the people in the trial were randomly assigned to usual care (care provided by their primary care provider or a walk-in-clinic), while the other half were treated by a lung specialist and asthma/COPD educator (a specially-trained nurse or respiratory therapist).

Individuals treated by a lung specialist and educator were prescribed inhalers to treat their asthma or COPD and were taught how to use them. Some were given action plans to help them manage disease flare-ups themselves. They were provided with smoking cessation treatment, exercise and weight counselling, and pneumonia and flu vaccines if appropriate.

Ninety-two per cent of patients seen by a lung specialist and asthma/COPD educator started new medications for asthma or COPD, compared to 60 per cent of patients who received usual care.

Treating undiagnosed asthma, COPD leads to fewer healthcare visits

The researchers found that patients seen by a lung specialist and asthma/COPD educator averaged 0.53 healthcare visits per year for respiratory symptoms in the year after diagnosis, compared to 1.12 visits in the usual care group.

In addition, patients seen by a lung specialist and asthma/COPD educator saw their average score on the St. George's Respiratory Questionnaire rise by 10.2 points, compared to 6.8 points for the usual care group. A four-point rise means an improvement in health and quality of life.

"In the real world, not everyone can see a lung specialist," explains Dr. Aaron. "The good news is that as long as a patient gets diagnosed and treated, their symptoms will improve. The people in our study who went to primary care providers and walk-in clinics had great outcomes, and those who went to a lung specialist and asthma/COPD educator had excellent outcomes."

"Asthma diagnosis makes a big difference," says study participant

Jazzminn Hein was 24 years old and had recently given birth to her first child when she got the call inviting her to join the study. Carrying a few loads of laundry up the stairs or talking on the phone for 10 minutes would leave her breathless. She didn't see the downside to getting a breathing test.

“For years I told doctors about this elephant on my chest and struggling to breathe. They said it was my anxiety, that I was having panic attacks." remembers Jazzminn.

But it wasn't panic attacks. It was asthma. Asthma that she'd likely had since grade school. A daily inhaler turned her symptoms around.

“The asthma diagnosis makes a big difference," she says. "Your muscles need oxygen, and when you can’t breathe properly it makes you sore and tired all the time. I’ve noticed an increase in energy. I have two small kids now and I can keep up with them. I sleep better because I used to regularly wake up struggling to breathe."

Asthma affects eight per cent of Canadian adults and can develop at any age, while COPD affects eight per cent of Canadians over the age of 60.

"If you have breathing symptoms like mine, go to your doctor or a walk-in clinic and ask for a spirometry test," recommends Jazzminn. "The worst that can happen is that you'll have wasted your time. But if you do have a respiratory disease and get it properly treated, you'll be able to do things you hadn’t realized you missed."

Dr. Aaron agrees with Jazzminn. He thinks the best way to catch more cases of undiagnosed asthma and COPD is for patients to advocate for themselves. His past research found that even early stages of these diseases are linked with worse quality of life, greater healthcare use and decreased work productivity.

"Many people know to ask for breast cancer and colon cancer tests when they see certain signs. Ideally, they'd ask for a spirometry test when they notice symptoms of chronic respiratory diseases," says Dr. Aaron. "People don’t have to put up with these breathing problems when there is effective treatment available."

Full reference: Early Diagnosis and Treatment of COPD and Asthma: A Randomized, Controlled Trial. Shawn D. Aaron, Katherine L. Vandemheen, G. A. Whitmore, Celine Bergeron, Louis-Philippe Boulet, Andreanne Cote, Andrew McIvor, Erika Penz, Stephen K. Field, Catherine Lemière, Irvin Mayers, Mohit Bhutani, Tanweer Azher, Diane Lougheed, Samir Gupta, Nicole Ezer, Christopher J. Licskai, Paul Hernandez, Martha Ainslie, Gonzalo G Alvarez, Sunita Mulpuru, for the UCAP investigators. New England Journal of Medicine. May 19, 2024.

Funding: This study was funded by the Canadian Institutes of Health Research.

The Ottawa Hospital (TOH) is one of Canada’s top learning and research hospitals where we are guided by our vision to provide the world-class and compassionate care we would all want for our loved ones. Our multi-campus hospital, affiliated with the University of Ottawa, is home to the Regional Trauma Centre and Cancer Centre, and to discoveries that are adopted globally. Backed by generous support from the community, we are focused on reshaping the future of health care to improve the health of our diverse population of patients from Eastern Ontario, Western Quebec, and Nunavut. For more information, visit ohri.ca.


The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe. www.uottawa.ca

Jennifer Ganton
Director, Communications and Public Relations

Ottawa Hospital Research Institute
613-614-5253
jganton@ohri.ca

END

[Attachments] See images for this press release:
World-first trial shows benefits of finding, treating undiagnosed asthma and COPD

ELSE PRESS RELEASES FROM THIS DATE:

Acetaminophen shows promise in warding off acute respiratory distress syndrome, organ injury in patients with sepsis

2024-05-19
A National Institutes of Health (NIH)-supported clinical trial has found that intravenous acetaminophen reduced sepsis patients’ risk of having organ injury or developing acute respiratory distress syndrome, a serious condition that allows fluid to leak into the lungs. Sepsis is the body’s uncontrolled and extreme response to an infection. While the trial did not improve mortality rates in all patients with sepsis regardless of severity, the researchers found that acetaminophen gave the greatest benefit to the patients most at risk for organ damage. With the therapy, those patients needed less assisted ...

Bisoprolol in patients with COPD at high risk of exacerbation

2024-05-19
About The Study: Among people with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation, treatment with the β1-selective β-blocker bisoprolol did not reduce the number of self-reported COPD exacerbations requiring treatment with oral corticosteroids, antibiotics, or both. Quote from corresponding author Graham Devereux, M.D.: “People with COPD are at increased risk of cardiovascular conditions that benefit from treatment with beta-blockers. However, there is a well-documented ...

Pamrevlumab for idiopathic pulmonary fibrosis

2024-05-19
About The Study: Among patients with idiopathic pulmonary fibrosis treated with pamrevlumab (a fully human monoclonal antibody that binds to and inhibits connective tissue growth factor activity) or placebo, there was no statistically significant between-group difference for the primary outcome of absolute change in forced vital capacity from baseline to week 48.  Quote from corresponding author, Ganesh Raghu, M.D.: “Current treatment with the two drugs approved by regulatory agencies ...

Acetaminophen for prevention and treatment of organ dysfunction in critically ill patients with sepsis

2024-05-19
About The Study: In critically ill sepsis patients, treatment with intravenous acetaminophen for 5 days was safe but did not improve the primary end point of days alive and free of any organ support (dialysis, assisted ventilation, and vasopressors) to day 28 compared with placebo.   Corresponding Author: To contact the corresponding author, Lorraine B. Ware, M.D., email Lorraine.ware@vumc.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.8772) Editor’s Note: Please see the ...

Measuring lung function more accurately and more equitably

2024-05-19
Removing race from equations that estimate lung function will shift the categorization of disease severity across patient populations, moving more Black individuals into an advanced disease category, according to new research led by scientists at Harvard Medical School. At the same time, more white and Hispanic people would be reclassified as having less advanced illness. The findings, the research team said, suggest that adjusting lung function tests to include race — as has been the case historically — likely normalized worse lung function and downplayed disease severity among Black people. The work, to be published May 19 in the New England Journal ...

Study reports ‘excellent’ outcomes for patients receiving optimized treatment for atrial fibrillation

2024-05-18
Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone. In a new study published in Heart Rhythm,  researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, analyzed real-world clinical data to measure the impact of evidence-based best-practices on patient outcomes for the most common AF procedure: radiofrequency (RF)-based ablation. One year after the procedure, 81.6 percent ...

Modular Communicative Leadless ICD is safe and exceeds performance expectations

2024-05-18
Wireless implantable cardioverter-defibrillators (ICDs) eliminate the lead-related complications that come with a wired ICD, but they are unsuitable for patients with ventricular tachycardia, when the heart beats too quickly, or bradycardia, when the resting heart rate is seen as low. Research led by Amsterdam UMC, that is published today in the New England Journal of Medicine, shows that the first wireless modular system suitable for these patient groups is safe and exceeds performance expectations. Opening the door for a wider ...

Patients seen by female gastroenterologists have significantly less health care utilization than patients seen by male providers

2024-05-18
WASHINGTON, DC (May 18, 2024) — Patients seen by a female gastroenterologist for an initial consultation are less likely to use medical care in the emergency department, hospital or primary care office for two years after their visit when compared to patients initially seen by male gastroenterologists, according to a study to be presented at Digestive Disease Week® (DDW) 2024. “If there really is something different about the way female and male gastroenterologists provide care that impacts patient outcomes, it will be important to share these learnings broadly among health care providers ...

Iso-propagation vortices: optical multiplexing for unprecedented information capacity

Iso-propagation vortices: optical multiplexing for unprecedented information capacity
2024-05-17
The future of optical communications just got brighter. In a groundbreaking development reported in Advanced Photonics, researchers from Nanjing University have introduced iso-propagation vortices (IPVs), a novel concept that offers a solution to a long-standing challenge faced by scientists and engineers: how to increase information processing capacity while overcoming the limitations of traditional vortex beams. Challenge: divergence and beam size Multiplexing of optical degrees of freedom, such as polarization and wavelength, has been a staple in enhancing communication capacity. ...

Ukraine blackouts caused by malware attacks warn against evolving cybersecurity threats to the physical world

2024-05-17
On a cold winter night in 2016, Ukrainians experienced the first-ever known blackout caused by malicious code (malware) designed to autonomously attack the power grid. One-fifth of Kyiv’s citizens were plunged into darkness as attackers used malware to target the capital city’s power grid. Six years later, in the early months of the ongoing Russia-Ukraine war, a second attack attempted to combine kinetic and cyber attacks to take down Ukraine’s power grid. Malware attacks against physical ...

LAST 30 PRESS RELEASES:

New prognostic model enhances survival prediction in liver failure

China focuses on improving air quality via the coordinated control of fine particles and ozone

Machine learning reveals behaviors linked with early Alzheimer’s, points to new treatments

Novel gene therapy trial for sickle cell disease launches

Engineering hypoallergenic cats

Microwave-induced pyrolysis: A promising solution for recycling electric cables

Cooling with light: Exploring optical cooling in semiconductor quantum dots

Breakthrough in clean energy: Scientists pioneer novel heat-to-electricity conversion

Study finds opposing effects of short-term and continuous noise on western bluebird parental care

Quantifying disease impact and overcoming practical treatment barriers for primary progressive aphasia

Sports betting and financial market data show how people misinterpret new information in predictable ways

Long COVID brain fog linked to lung function

Concussions slow brain activity of high school football players

Study details how cancer cells fend off starvation and death from chemotherapy

Transformation of UN SDGs only way forward for sustainable development 

New study reveals genetic drivers of early onset type 2 diabetes in South Asians 

Delay and pay: Tipping point costs quadruple after waiting

Magnetic tornado is stirring up the haze at Jupiter's poles

Cancers grow uniformly throughout their mass

Researchers show complex relationship between Arctic warming and Arctic dust

Brain test shows that crabs process pain

Social fish with low status are so stressed out it impacts their brains

Predicting the weather: New meteorology estimation method aids building efficiency

Inside the ‘swat team’ – how insects react to virtual reality gaming 

Oil spill still contaminating sensitive Mauritius mangroves three years on

Unmasking the voices of experience in healthcare studies

Pandemic raised food, housing insecurity in Oregon despite surge in spending

OU College of Medicine professor earns prestigious pancreatology award

Sub-Saharan Africa leads global HIV decline: Progress made but UNAIDS 2030 goals hang in balance, new IHME study finds

Popular diabetes and obesity drugs also protect kidneys, study shows

[Press-News.org] World-first trial shows benefits of finding, treating undiagnosed asthma and COPD